Copyright
©The Author(s) 2025.
World J Clin Cases. Sep 6, 2025; 13(25): 107907
Published online Sep 6, 2025. doi: 10.12998/wjcc.v13.i25.107907
Published online Sep 6, 2025. doi: 10.12998/wjcc.v13.i25.107907
Table 1 Effects of nitric oxide on lung cancer models
Factor | Models | Effects | Ref. |
Nitric oxide | H460 cell line | Migratory | [40] |
LLC-1 cell line | Apoptotic | [41] | |
Lung cancer patient | Tumorigenic | [42] | |
Lung cancer tissue | Anti-apoptotic | [43] | |
NCI-H292 cell line | Anti-apoptotic | [44] | |
H23 cell line | Migratory | [45] | |
Lung cancer patient | Tumorigenic | [46] | |
H292 and H460 cell lines | Tumorigenic | [47] | |
H23, H292, and H460 cell lines | Migratory | [48] | |
Anoikis-resistant H460 cell line | Metastatic | [49] | |
A549, H1299, and CL3 cell lines | Apoptotic | [50] | |
Cisplatin-resistant A549 cells | Drug resistance | [51] | |
KRAS mutation-positive mice | Growth | [52] | |
A549 and H3255 cell lines | Radiation resistance | [53] | |
- | Stemness maintenance | [54] | |
LUAD patient | Tumorigenic | [55] |
- Citation: Demirel S, Sinag IN. Role of nitric oxide, prostaglandins, thromboxanes and endothelins in lung cancer: An overview. World J Clin Cases 2025; 13(25): 107907
- URL: https://www.wjgnet.com/2307-8960/full/v13/i25/107907.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v13.i25.107907